HLA-class Ib family include HLA-E, -F, -G, and -H molecules that, in contrast with high polymorphic HLA-class Ia molecules (HLA-A, -B, and -C), display a limited polymorphism, with a small number of alleles encoding limited functional proteins. Similar to HLA-class Ia molecules, HLAclass Ib molecules bind peptides generated from cytosolic antigens and present them to CD8 + T lymphocytes, but their main function is the regulation of immune responses, both in physiological and pathological conditions. HLA-G, the best characterized HLA-Ib molecule, is expressed on fetal cytotrophoblast cells during pregnancy and abrogates maternal NK cell cytotoxicity against fetal tissues. However, HLA-G is also expressed (or released as soluble molecules) by different cells and tissues in pathological contexts such as tumors, grafted organs, pathogen-infected cells, and inflammatory tissues. HLA-G interacts with specific receptors on T and B lymphocytes, NK cells, neutrophils, and antigen presenting cells, inhibiting their function. HLA-E is virtually expressed by all nucleated cells and binds peptides derived from HLA-class I molecules leader sequence. In physiological conditions, it interacts with CD94/NKG2A inhibitory receptor on NK cells, inhibiting their cytotoxicity against cells displaying normal HLA-class I molecules expression. When such molecules are downregulated (i.e., transformed or infected cells), HLA-class I-derived peptides are lower and subsequently HLA-E expression is dampened, allowing NK cells lo lyse these cells. However, different transformed cells upregulate HLA-E expression to avoid NKcell mediated lysis. Limited information is available regarding HLA-F function. This molecule acts as chaperone for the 2-microglobulin-free heavy chain of other HLA-class I molecules, and it is expressed on the surface of activated lymphocytes. So far, no functional HLA-H molecules encoded by HLA-H genes have been characterized.
In the present issue dedicated to these nonclassical HLAclass Ib molecules, two papers have analyzed some basic aspects of HLA-G. Finally, the expression and function of HLA-E have been investigated by F. Morandi et al., whohave demonstrated that IL-27 treatment upregulated HLA-E expression on human monocytes, rendering the latter cells immunosuppressive, through the inhibition of IFN-secretion by NK cells.
In conclusion, the papers in this issue will help to enrich the current knowledge regarding HLA-Ib molecules and their role in physiological and pathological conditions.
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